mitoxantrone has been researched along with Chronic Kidney Diseases in 1 studies
Mitoxantrone: An anthracenedione-derived antineoplastic agent.
mitoxantrone : A dihydroxyanthraquinone that is 1,4-dihydroxy-9,10-anthraquinone which is substituted by 6-hydroxy-1,4-diazahexyl groups at positions 5 and 8.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kaneko, H | 1 |
| Katoh, T | 1 |
| Hirano, I | 1 |
| Hasegawa, A | 1 |
| Tsujita, T | 1 |
| Yamamoto, M | 1 |
| Shimizu, R | 1 |
1 other study available for mitoxantrone and Chronic Kidney Diseases
| Article | Year |
|---|---|
Induction of erythropoietin gene expression in epithelial cells by chemicals identified in GATA inhibitor screenings.
Topics: Anemia; Animals; Base Sequence; Cells, Cultured; CRISPR-Cas Systems; Epithelial Cells; Erythropoieti | 2017 |